Compare BLCO & S Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLCO | S |
|---|---|---|
| Founded | 1853 | 2013 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.1B |
| IPO Year | N/A | N/A |
| Metric | BLCO | S |
|---|---|---|
| Price | $17.74 | $13.43 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 30 |
| Target Price | $17.25 | ★ $21.47 |
| AVG Volume (30 Days) | 364.8K | ★ 8.8M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.08 | $24.53 |
| Revenue Next Year | $5.85 | $20.04 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.45 | $12.43 |
| 52 Week High | $17.91 | $24.97 |
| Indicator | BLCO | S |
|---|---|---|
| Relative Strength Index (RSI) | 62.61 | 43.85 |
| Support Level | $16.60 | $12.88 |
| Resistance Level | $17.45 | $14.04 |
| Average True Range (ATR) | 0.51 | 0.76 |
| MACD | 0.07 | 0.02 |
| Stochastic Oscillator | 92.22 | 33.73 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
SentinelOne is a cloud-based cybersecurity company specializing in endpoint protection. SentinelOne's primary offering is its Singularity platform that offers a single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The California-based firm was founded in 2013 and went public in 2021.